Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Gel-Like Polymers May Improve Stem Cell-Based Therapies.

Posted by barb@stemsave.com on Oct 8, 2014 6:41:15 AM

Scientists are developing a polymeric gel to protect stem cells from trauma during transplant injections.

Complex chemical polymers are currently being developed by scientists at Stanford University to protect and support the proliferation of stem cells during spinal cord transplantation procedures. The gels are designed to provide padding for the cells during injection, while also varying in viscosity and the biochemical signals contained within to offer stem cells an optimal environment for differentiation.

Read More

Topics: traumatic brain injuries, stemsaveblog, Brain, Bone, Debilitating Diseases, Stemcells, Knee, autologousstemcells, spinal cord injuries, Spinal Muscular Atrophy, Blood vessel

FSHD Study Utilizes Stem Cells

Posted by barb@stemsave.com on Sep 9, 2014 5:48:00 AM

A new potential treatment for FSHD utilizes stem cells to regenerate the muscle lost to protein DUX4.

In a recently published study by the University of Minnesota, researchers are utilizing skeletal muscle stem cells in an animal model designed to study the muscle-degenerative protein DUX4 found in patients with facioscapulohumeral muscular dystrophy [FSHD]. The team was able to harvest the muscle stem cells from one mouse with FSHD and transplant them into a recipient mouse, allowing the recipient to regenerate new muscle as long as DUX4 was not activated.

Read More

Topics: Muscular Dystrophy, stemsaveblog, Duchenne Muscular Dystrophy, Debilitating Diseases, Stemcells, autologousstemcells, Spinal Muscular Atrophy

Anti-Aging Properties of MSCs

Posted by anna@stemsave.com on Aug 1, 2014 5:54:37 AM

Mesenchymal Stem Cells are able to stimulate muscle-building cells that lose function with age.

A recently published study by University of Illinois Kinesiology and Community Health Professor Marni Boppart has identified mesenchymal stem cells [MSCs] as a tool for rejuvenating muscle to prevent age-related injuries and disabilities. In addition to their ability to differentiate into other cell types, MSCs were found to secrete growth factors that stimulate the activation of the multiple cell types comprising skeletal muscle, including muscle precursor cells and satellite cells, which lose function with age.

Read More

Topics: Muscular Dystrophy, Paralysis, stemsaveblog, clinical trials, Duchenne Muscular Dystrophy, Debilitating Diseases, Stemcells, autologousstemcells, Spinal Muscular Atrophy

Muscle Degeneration Reversed Through Discovery of Stem Cell Pathways

Posted by barb@stemsave.com on Apr 4, 2014 7:35:24 AM

A new discovery in stem cell differentiation could lead to new treatments for muscle-wasting diseases.

Recent research from the University of Colorado Boulder has identified two stem cell signaling pathways that are directly related to the age-related degeneration of muscle tissue and the onset of a variety of muscle-wasting diseases, such as muscular dystrophy and sarcopenia. By altering these pathways, the investigators were able to enhance muscle stem cell renewal and improve muscle regeneration.

Read More

Topics: Muscular Dystrophy, stemsaveblog, clinical trials, Duchenne Muscular Dystrophy, Debilitating Diseases, Stemcells, autologousstemcells, Spinal Muscular Atrophy

Spinal Cord Injury Stem Cell Treatment Enters Clinical Trials.

Posted by barb@stemsave.com on Mar 7, 2014 9:41:22 AM


A new treatment aims to treat spinal cord injuries by injecting stem cells into the spinal cord.

A medical team from the University of Calgary is now recruiting candidates to participate in the phase one clinical trial for a new stem cell therapy that aims to treat spinal cord injuries. The researchers plan to inject stem cells into the spinal cord two sites above and two sites below the point of injury to recreate lost or damaged tissue.

Read More

Topics: stemsaveblog, clinical trials, Debilitating Diseases, Phase II, Stemcells, autologousstemcells, spinal cord injuries, Spinal Muscular Atrophy

Autologous Stem Cell Therapy Could Offer Treatment for SMA Patients

Posted by anna@stemsave.com on Jan 17, 2013 11:50:46 AM

 

 

 

 

 

 

As the most common genetic neurological disease contributing to infant mortality, researchers have been exploring the utility of autologous stem cell therapies (or therapies that use a patient's own stem cells) in treating Spinal muscular atrophy (SMA).

Read More

Topics: stemsaveblog, autologousstemcells, Spinal Muscular Atrophy

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all